LZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of β-catenin

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 12, 2014, Pages 1997-2008

  Wang, Linbo ^a   Guo, Jufeng ^a   Wang, Qinchuan ^a   Zhou, Jichun ^a   Xu, Chenpu ^a   Teng, Rongyue ^a   Chen, Yongxia ^a   Wei, Qun ^a,b   Liu, Zhi Ping ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

EMT; Gastric cancer; LZTFL1; Metastasis; MMP; Catenin

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; GELATINASE A; GELATINASE B; LZTFL1 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ACTIVE TRANSPORT; ADULT; AGED; CELL MOTION; CELL NUCLEUS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; STOMACH TUMOR; TUMOR INVASION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADULT; AGED; BETA CATENIN; CELL MOVEMENT; CELL NUCLEUS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84925228258     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1753-9     Document Type: Article

References (55)

1. Aigner K, Dampier B, Descovich L et al (2007) The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26:6979–6988
2. Batlle E, Sancho E, Franci C et al (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84–89
3. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M et al (2009) Recent patterns in gastric cancer: a global overview. Int J Cancer 125:666–673
4. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG et al (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76–83
5. Chan AO, Wong BC, Lan HY, Loke SL, Chan WK, Hui WM et al (2003) Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. J Gastroenterol Hepatol 18:534–539
6. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze’ev A (2003) Autoregulation of E-cadherin expression by cadherin–cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163:847–857
7. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P et al (1989) The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18:2883–2891
8. Di Croce L, Pelicci PG (2003) Tumour-associated hypermethylation: silencing E-cadherin expression enhances invasion and metastasis. Eur J Cancer 39:413–414
9. Floor S, van Staveren WC, Larsimont D, Dumont JE, Maenhaut C (2001) Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations. Oncogene 30:4609–4621
10. Gheldof A, Berx G (2013) Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci 116:317–336
11. Gomes LR, Terra LF, Sogayar MC, Labriola L (2011) Epithelial-mesenchymal transition: implications in cancer progression and metastasis. Curr Pharm Biotechnol 12:1881–1890
12. Grabsch H, Sivakumar S, Gray S, Gabbert HE, Müller W (2010) HER2 expression in gastric cancer: rare, heterogeneous and of no prognostic value—conclusions from 924 cases of two independent series. Cell Oncol 32(1–2):57–65
13. Hajra KM, Chen DY, Fearon ER (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62:1613–1618
14. Hatsell S, Rowlands T, Hiremath M, Cowin P (2003) Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8(2):145–158
15. Hendriksen J, Jansen M, Brown CM, van der Velde H, van Ham M, Galjart N et al (2008) Plasma membrane recruitment of dephosphorylated beta-catenin upon activation of the Wnt pathway. J Cell Sci 121:1793–1802
16. Hesson LB, Cooper WN, Latif F (2007) Evaluation of the 3p21.3 tumor-suppressor gene cluster. Oncogene 26:7283–7301
17. Howe LR, Watanabe O, Leonard J, Brown AM (2003) Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 63:1906–1913
18. Ieni A, Barresi V, Giuffrè G, Caruso RA, Lanzafame S, Villari L et al (2013) HER2 status in advanced gastric carcinoma: a retrospective multicentric analysis from Sicily. Oncol Lett 6:1591–1594
19. Ji L, Minna JD, Roth JA (2005) 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol 1:79–92
20. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150
21. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67
22. Kiss H, Kedra D, Kiss C, Kost-Alimova M, Yang Y, Klein G et al (2001) The LZTFL1 gene is a part of a transcriptional map covering 250 kb within the common eliminated region 1 (C3CER1) in 3p21.3. Genomics 73:10–19
23. Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ et al (2011) Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci 102:815–827
24. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730
25. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715
26. Marion V, Stutzmann F, Gérard M, De Melo C, Schaefer E, Claussmann A et al (2012) Exome sequencing identifies mutations in LZTFL1, a BBSome and smoothened trafficking regulator, in a family with Bardet–Biedl syndrome with situs inversus and insertional polydactyly. J Med Genet 49:317–321
27. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW et al (1993) E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53:1690–1695
28. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790
29. Murai T, Yamada S, Fuchs BC, Fujii T, Nakayama G, Sugimoto H et al (2014) Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer. J Surg Oncol 109:684–689
30. Niehrs C (2012) The complex world of WNT receptor signaling. Nat Rev Mol Cell Biol 13(12):767–779
31. Nisticò P, Bissell MJ, Radisky DC (2012) Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harb Perspect Biol 4(2):pii: a011908
32. Ohtsu A, Yoshida S, Saijo N (2006) Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol 24:2188–2196
33. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68:3645–3654
34. Orlichenko LS, Radisky DC (2008) Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis 25:593–600
35. Orsulic S, Huber O, Aberle H, Arnold S, Kemler R (1999) E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 112:1237–1245
36. Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y et al (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303:1729–1737
37. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS et al (1999) Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 59:4257–4260
38. Peleteiro B, Bastos A, Ferro A, Lunet N (2014) Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci. doi:10.1007/s10620-014-3063-0
39. Przybylo JA, Radisky DC (2007) Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail’s pace. Int J Biochem Cell Biol 39:1082–1088
40. Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER (1999) Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 154:325–329
41. Rosenbluh J, Wang X, Hahn WC (2014) Genomic insights into WNT/β-catenin signaling. Trends Pharmacol Sci 35(2):103–109
42. Rowlands TM, Pechenkina IV, Hatsell S, Cowin P (2004) Beta-catenin and cyclin D1: connecting development to breast cancer. Cell Cycle 3:145–148
43. Sasaki Y, Morimoto I, Kusano M, Hosokawa M, Itoh F, Yanagihara K, Imai K et al (2001) Mutational analysis of the beta-catenin gene in gastric carcinomas. Tumor Biol 22:123–130
44. Schmalhofer O, Brabletz S, Brabletz T (2009) E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28:151–166
45. Seo S, Zhang Q, Bugge K, Breslow DK, Searby CC, Nachury MV et al (2011) A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened. PLoS Genet 7:e1002358
46. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426
47. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871–890
48. Vinson C, Acharya A, Taparowsky EJ (2006) Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim Biophys Acta 1759(1–2):4–12
49. Wagner AD, Grothe W, Behl S, Kleber G, Grothey A, Haerting J et al (2005) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev (2):CD004064. doi:10.1002/14651858.CD004064.pub3
50. Wang Q, Sun ZX, Allgayer H, Yang HS (2010) Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells. Oncogene 29:128–138
51. Wei Q, Zhou W, Wang W, Gao B, Wang L, Cao J, Liu ZP (2010) Tumor-suppressive functions of leucine zipper transcription factor-like 1. Cancer Res 70:2942–2950
52. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH (2001) Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int J Cancer 5:108–113
53. Wu HW, Qin CY, Huang JL et al (2014) Correlations of β-catenin, Ki67 and Her-2/neu with gastric cancer. Asian Pac J Trop Med 7(4):257–261
54. Yokoyama K, Kamata N, Fujimoto R, Tsutsumi S, Tomonari M, Taki M et al (2003) Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int J Oncol 22:891–898
55. Yoong J, Michael M, Leong T (2011) Targeted therapies for gastric cancer: current status. Drugs 71:1367–1384